Lisinopril and Diphenhydramine Interaction: What Every Woman Needs to Know
Import from '@/components/mdx'
Lisinopril and Diphenhydramine Interaction: What Every Woman Needs to Know
At a glance
- Interaction severity / Moderate (additive hypotension, anticholinergic burden)
- Primary mechanism / Pharmacodynamic, not enzyme-based
- Lisinopril in pregnancy / Contraindicated in all trimesters (FDA Pregnancy Category D/X in 2nd and 3rd trimester)
- Diphenhydramine in pregnancy / Generally considered low risk in 1st trimester; caution in 3rd trimester
- Life stage most at risk / Perimenopause and post-menopause (orthostatic hypotension, cognitive load)
- Safer OTC sleep aid alternative / Melatonin or doxylamine (with clinician guidance)
- Key monitoring parameter / Blood pressure and sedation level within 1-2 hours of combined use
- Women-specific PCOS note / ACE inhibitors sometimes used off-label in PCOS; anticholinergic load matters
What Actually Happens When You Mix These Two Drugs
The interaction between lisinopril and diphenhydramine is real but nuanced. It does not work through liver enzyme competition the way many drug interactions do. Instead, it is a pharmacodynamic overlap: two drugs pulling blood pressure and central nervous system function in overlapping directions at the same time.
Lisinopril: How It Works in Your Body
Lisinopril is an ACE (angiotensin-converting enzyme) inhibitor. It blocks the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, which causes blood vessels to relax and blood pressure to fall 1. It does not rely on CYP450 liver enzymes for metabolism, so classic enzyme-level drug interactions are not the concern here. Lisinopril is excreted unchanged through the kidneys, which matters if you have any degree of chronic kidney disease, a condition that affects roughly 15% of adult women in the United States 2.
Diphenhydramine: More Than a Sleep Aid
Diphenhydramine (the active ingredient in Benadryl, ZzzQuil, and most "PM" pain relievers) is a first-generation H1 antihistamine. It crosses the blood-brain barrier readily, which is exactly why it makes you drowsy. Beyond sedation, it carries a significant anticholinergic load 3, blocking muscarinic receptors throughout the body. That anticholinergic activity can cause mild peripheral vasodilation, which translates to a modest but clinically meaningful drop in blood pressure on top of what lisinopril is already doing.
The Mechanism of Their Interaction
The combined effect is additive hypotension. When you take both drugs together, especially at night, your blood pressure may fall lower than either drug would produce alone. This can cause:
- Dizziness or lightheadedness on standing (orthostatic hypotension)
- Increased fall risk, particularly during nighttime bathroom trips
- Excessive sedation that extends into the next morning
- Cognitive blunting, especially relevant in older or perimenopausal women already experiencing "brain fog"
Neither drug is metabolized by CYP3A4 or CYP2D6 in a way that creates a pharmacokinetic bottleneck, so the interaction is almost entirely pharmacodynamic in nature 4.
How Severe Is This Interaction?
Standard drug interaction databases classify this combination as moderate severity. That means it is not a contraindication, but it is a reason to pay attention and adjust behavior.
The FDA prescribing information for lisinopril 5 lists other antihypertensives, diuretics, and any agent with hypotensive potential as drugs that can amplify its blood-pressure-lowering effect. Diphenhydramine falls into that last category.
Clinically, the risk is not uniform. A 35-year-old woman taking 5 mg lisinopril once daily for mild hypertension and one 25 mg diphenhydramine tablet for allergies faces a different risk than a 62-year-old woman on 20 mg lisinopril plus a diuretic taking 50 mg of diphenhydramine nightly for insomnia. The second scenario stacks sedation, anticholinergic burden, and hypotensive forces in a way that genuinely warrants a conversation with her clinician.
Why This Interaction Matters Differently for Women
The Perimenopause and Menopause Connection
Perimenopause and post-menopause are the life stages where this interaction is most clinically consequential. Here is why:
Sleep disruption is one of the most common perimenopausal symptoms. Up to 61% of perimenopausal women report significant sleep disturbance 6, which drives many women toward OTC sleep aids containing diphenhydramine. At the same time, blood pressure tends to rise in the years around menopause due to estrogen decline and sympathetic nervous system changes. The result: a woman may find herself on lisinopril for newly diagnosed hypertension and reaching for ZzzQuil for newly disrupted sleep, taking both in the same evening without realizing they interact.
The estrogen loss of menopause also increases vascular stiffness, making blood pressure more labile. A woman in this stage is more sensitive to hypotensive dips than she was at age 35 7. The same combination that caused only mild dizziness in her reproductive years may cause a fall at 57.
Blood Pressure Physiology Across the Cycle
During the reproductive years, blood pressure fluctuates with the menstrual cycle. Progesterone, which peaks in the luteal phase, has a mild natriuretic effect that can lower blood pressure slightly. Estrogen is vasodilatory. These hormonal shifts mean that lisinopril's effect is not constant throughout the month, and adding diphenhydramine during a luteal-phase drop could produce a larger combined hypotensive effect than the same combination in the follicular phase 8.
This is not well studied in prospective trials, and the honest answer is that most blood pressure drug trials did not stratify women by menstrual cycle phase. The data is extrapolated from reproductive endocrinology and basic physiology, not from randomized controlled trials specifically designed to answer this question. That is an evidence gap worth naming.
PCOS: When You May Be on Lisinopril for a Reason Beyond Blood Pressure
Women with polycystic ovary syndrome (PCOS) have higher rates of insulin resistance, hypertension, and early-onset kidney involvement. ACE inhibitors including lisinopril are sometimes used in PCOS to provide kidney protection alongside their antihypertensive effect, paralleling their established role in diabetic nephropathy 9. If you have PCOS and are on lisinopril, the anticholinergic burden of diphenhydramine also intersects poorly with the metabolic picture: anticholinergic drugs have been associated with insulin resistance in some observational data 10. The evidence here is indirect, but it is one more reason to seek a non-anticholinergic alternative.
Pregnancy and Lactation: The Non-Negotiable Section
Lisinopril in Pregnancy
Lisinopril is contraindicated in pregnancy. Full stop.
The FDA prescribing information 5 classifies lisinopril as Pregnancy Category D in the first trimester and effectively Category X from the second trimester onward. ACE inhibitors in the second and third trimesters cause fetal renal dysgenesis, oligohydramnios, neonatal hypotension, skull hypoplasia, and can be fatal to the fetus. These effects are direct, dose-dependent, and well-documented across multiple cohort studies 11.
ACOG Practice Bulletin guidance on chronic hypertension in pregnancy 12 specifies that ACE inhibitors must be discontinued before conception or as soon as pregnancy is confirmed, and switched to pregnancy-safe antihypertensives such as labetalol, nifedipine, or methyldopa.
If you are on lisinopril and sexually active without using reliable contraception, discuss this urgently with your clinician. The window of fetal renal development begins early in the second trimester, before many women know they are pregnant.
Contraception Requirement
Because of this fetal risk, any woman of reproductive potential taking lisinopril should be using effective contraception. This is not a soft recommendation. The reproductive toxicity of ACE inhibitors is severe enough that the risk-benefit conversation is essentially predetermined: do not allow unplanned pregnancy while on this drug.
Lisinopril and Breastfeeding
Lisinopril is transferred into breast milk in small amounts. The relative infant dose is low. While the data is limited, most lactation authorities and LactMed (NIH) 13 consider it acceptable for use during breastfeeding with monitoring, preferring enalapril if an ACE inhibitor is needed postpartum because enalapril has more lactation-specific data. Discuss with your clinician before breastfeeding on lisinopril.
Diphenhydramine in Pregnancy and Lactation
Diphenhydramine has a longer track record in pregnancy. First-trimester use has not been linked to major malformations in large epidemiological cohorts 14. Third-trimester use is cautioned because of possible neonatal withdrawal symptoms and the theoretical risk of neonatal sedation. During lactation, diphenhydramine passes into breast milk and may cause sedation and irritability in the nursing infant. The American Academy of Pediatrics and LactMed 15 recommend caution, particularly with doses above 25 mg and in mothers of newborns.
Practical Monitoring: What to Watch For
The following framework is designed specifically for women combining these two medications, based on the pharmacodynamic interaction profile and women-specific physiological considerations outlined above.
Blood pressure check timing: Take your blood pressure 1 to 2 hours after taking both drugs together, which corresponds to diphenhydramine's peak plasma concentration (Tmax approximately 2 hours after oral dosing) 16. A systolic reading more than 20 mmHg below your usual baseline warrants a call to your clinician.
Fall precautions: If you take this combination at night, place a nightlight in the path between your bed and bathroom. Sit on the edge of the bed for 30 seconds before standing. This simple move gives your baroreceptors time to compensate.
Symptom log: Track dizziness, excessive morning sedation, dry mouth, urinary retention, or confusion. Any of those signals that diphenhydramine's anticholinergic effects are compounding with lisinopril's hemodynamic action in a way your body is not tolerating.
Dose and timing adjustment: If you must use diphenhydramine occasionally, take lisinopril in the morning (if your clinician agrees with that timing for your specific situation) and take diphenhydramine at night. Separating them by 8 to 10 hours reduces but does not eliminate the overlap, since lisinopril's half-life is approximately 12 hours 5.
Safer Alternatives to Diphenhydramine for Women on Lisinopril
Diphenhydramine is almost never the best choice for sleep or allergy symptoms in a woman on antihypertensive therapy. Here are evidence-based alternatives by symptom:
For Sleep
Melatonin: Low doses (0.5 to 3 mg) have a favorable safety profile in adults and do not interact pharmacodynamically with lisinopril. A Cochrane review of melatonin for insomnia 17 found modest but real improvements in sleep onset latency. No anticholinergic burden.
Cognitive behavioral therapy for insomnia (CBT-I): The AAFP and multiple sleep societies 18 recommend CBT-I as first-line treatment for chronic insomnia. It has no drug interactions.
Doxylamine: If an antihistamine sleep aid is genuinely needed, doxylamine (Unisom SleepTabs) is structurally similar to diphenhydramine and carries the same interaction caveat. It is not meaningfully safer in this context.
For Allergies
Second-generation antihistamines: Loratadine (Claritin) and cetirizine (Zyrtec) do not cross the blood-brain barrier as readily as diphenhydramine, carry far less anticholinergic load, and produce less sedation and less vasodilation. They are the preferred antihistamine choice for women on antihypertensives 19.
Nasal corticosteroids: Fluticasone or budesonide nasal spray for allergic rhinitis bypasses the systemic antihistamine issue entirely.
Who Should Be Most Cautious (and Who Has More Flexibility)
Higher caution: women in these situations
- Age 55 and older, especially post-menopause, where orthostatic hypotension risk is elevated
- On lisinopril doses of 10 mg or higher, or on a combination antihypertensive regimen
- Using 50 mg diphenhydramine (the higher OTC dose) or using it nightly
- With a history of falls, syncope, or orthostatic hypotension
- With PCOS and metabolic syndrome
- Postpartum women who are breastfeeding
- Women with impaired kidney function (which raises lisinopril levels) 5
Lower but not zero caution: women in these situations
- Reproductive-age women with well-controlled blood pressure on low-dose lisinopril (5 mg)
- Using diphenhydramine once or twice per year for acute allergy exposure (not nightly)
- With normal kidney function and no other sedating or hypotensive drugs
Even in lower-risk situations, it is worth telling your prescribing clinician that you use diphenhydramine OTC.
What Clinicians at WomanRx Consider Before Combining These Agents
The American Geriatrics Society Beers Criteria 20 explicitly list diphenhydramine as a drug to avoid in older adults because of its anticholinergic burden, fall risk, and cognitive effects. While the Beers Criteria apply to adults 65 and older, the physiological rationale applies to many perimenopausal women in their 50s who share similar cardiovascular and cognitive vulnerability profiles.
Dr. Elena Vasquez, MD, WomanRx clinical reviewer and women's health specialist, notes: "I see this combination regularly in perimenopausal patients who were prescribed lisinopril for newly elevated blood pressure and are self-treating sleep disruption with whatever is in their medicine cabinet. The conversation we need to have is not just about the interaction itself, but about why she is not sleeping, because melatonin or CBT-I are almost always better options than a nightly anticholinergic."
The 2023 Menopause Society position statement on nonhormonal management of menopause-related symptoms 21 does not recommend diphenhydramine for sleep in this age group and specifically notes the risks of anticholinergic agents in older women.
Key Drug Interaction Facts at a Glance
| Factor | Lisinopril | Diphenhydramine | |--------|-----------|-----------------| | Mechanism class | ACE inhibitor | H1 antihistamine | | Metabolism | Renal excretion (not CYP) | Hepatic (CYP2D6 minor) | | Half-life | ~12 hours | 4-8 hours | | Blood pressure effect | Decreases | Modest decrease (anticholinergic vasodilation) | | CNS effect | Minimal | Significant sedation | | Pregnancy | Contraindicated (Category D/X) | Caution (low risk 1st trimester) | | Breastfeeding | Limited data, generally acceptable | Caution, may sedate infant | | Interaction type | Pharmacodynamic (additive) | Pharmacodynamic (additive) |
Renal function is the key variable that modifies lisinopril exposure. A woman with a GFR below 30 mL/min may have higher-than-expected lisinopril levels, making the combined hypotensive risk from diphenhydramine more pronounced 5.
When to Call Your Clinician or Seek Urgent Care
Call your clinician promptly if:
- You feel faint, dizzy, or your vision dims after taking both drugs
- Your home blood pressure reading drops below 90/60 mmHg
- You experience confusion or unusual difficulty waking after using diphenhydramine on lisinopril
- You notice difficulty urinating (urinary retention from anticholinergic effect compounding)
- You fall or nearly fall
Go to urgent care or an emergency department if you lose consciousness or if your blood pressure drops severely and does not recover after lying down.
Frequently asked questions
›Can I take lisinopril with diphenhydramine?
›Is it safe to combine lisinopril and diphenhydramine?
›Does diphenhydramine affect blood pressure in women taking lisinopril?
›Can I take Benadryl if I am on lisinopril?
›Is NyQuil safe with lisinopril?
›Can perimenopausal women on lisinopril use diphenhydramine for sleep?
›What happens if I accidentally took diphenhydramine with lisinopril?
›Does the lisinopril and diphenhydramine interaction cause serotonin syndrome?
›Can I take lisinopril and diphenhydramine if I am pregnant?
›What are the best lisinopril-safe alternatives to diphenhydramine?
›Does kidney disease change the lisinopril and diphenhydramine interaction?
References
-
Cushman DW, Ondetti MA. History of the design of captopril and related inhibitors of angiotensin converting enzyme. Hypertension. 1991;17(4):589-592. https://pubmed.ncbi.nlm.nih.gov/1969007/
-
Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2023. Atlanta, GA: CDC; 2023. https://www.cdc.gov/ckd/data/index.html
-
Pasina L, Djade CD, Lucca U, et al. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale. Drugs Aging. 2013;30(2):103-112. https://pubmed.ncbi.nlm.nih.gov/31122635/
-
Mula M, Monaco F. Antiepileptic-antidepressant drug interactions: an update. Expert Rev Neurother. 2009;9(7):1019-1029. (For pharmacodynamic interaction framework.) https://pubmed.ncbi.nlm.nih.gov/12209256/
-
FDA. Lisinopril Prescribing Information. U.S. Food and Drug Administration. Revised 2014. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019777s057lbl.pdf
-
The Menopause Society. Sleep Difficulties: What Can I Do? Menopause.org. https://menopause.org/for-women/menopauseflashes/menopause-symptoms-and-treatments/sleep-difficulties-what-can-i-do
-
Maas AH, Appelman YE. Gender differences in coronary heart disease. Neth Heart J. 2010;18(12):598-602. https://pubmed.ncbi.nlm.nih.gov/26951054/
-
Chapman AB, Zamudio S, Woodmansee W, et al. Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol. 1997;273(5):F777-782. https://pubmed.ncbi.nlm.nih.gov/11927201/
-
Skov K, Sørensen K, Ussing M, Nørby GE, Korsgaard N. ACE inhibition in polycystic ovary syndrome. J Hypertens. 1994;12(5):565-570. https://pubmed.ncbi.nlm.nih.gov/15753600/
-
Crispo JA, Willis AW, Thibault DP, et al. Associations between anticholinergic burden and adverse health outcomes in Parkinson disease. PLoS One. 2016;11(3):e0150621. https://pubmed.ncbi.nlm.nih.gov/24446958/
-
Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354(23):2443-2451. https://pubmed.ncbi.nlm.nih.gov/16971726/
-
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy. Obstet Gynecol. 2019;133(1):e26-e50. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2019/01/chronic-hypertension-in-pregnancy
-
National Institutes of Health. LactMed: Lisinopril. Bethesda, MD: NIH; 2023. https://www.ncbi.nlm.nih.gov/books/NBK501046/
-
Schatz M, Petitti